Michael Karsy, MD, PhD, MSc
Michael Karsy, MD, PhD, MSc
Thomas Jefferson University Hospital, Department of Neurosurgery
Verified email at hsc.utah.edu
Cited by
Cited by
Current progress on understanding microRNAs in glioblastoma multiforme
M Karsy, E Arslan, F Moy
Genes & cancer 3 (1), 3-15, 2012
Targeting the PI3K/AKT/mTOR signaling pathway in glioblastoma: novel therapeutic agents and advances in understanding
A Sami, M Karsy
Tumor Biology 34 (4), 1991-2002, 2013
Current understanding of the role and targeting of tumor suppressor p53 in glioblastoma multiforme
B England, T Huang, M Karsy
Tumor Biology 34 (4), 2063-2074, 2013
Established and emerging variants of glioblastoma multiforme: review of morphological and molecular features
M Karsy, M Gelbman, P Shah, O Balumbu, F Moy, E Arslan
Folia Neuropathol 50 (4), 301-321, 2012
A practical review of prognostic correlations of molecular biomarkers in glioblastoma
M Karsy, JA Neil, J Guan, MA Mahan, H Colman, RL Jensen
Neurosurgical focus 38 (3), E4, 2015
B-Raf and the inhibitors: from bench to bedside
T Huang, M Karsy, J Zhuge, M Zhong, D Liu
Journal of hematology & oncology 6 (1), 1-9, 2013
All-trans retinoic acid modulates cancer stem cells of glioblastoma multiforme in an MAPK-dependent manner
M Karsy, L Albert, ME Tobias, R Murali, M Jhanwar-Uniyal
Anticancer research 30 (12), 4915-4920, 2010
New molecular considerations for glioma: IDH, ATRX, BRAF, TERT, H3 K27M
M Karsy, J Guan, AL Cohen, RL Jensen, H Colman
Current neurology and neuroscience reports 17 (2), 19, 2017
Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility
N Gulati, M Karsy, L Albert, R Murali, M Jhanwar-Uniyal
International journal of oncology 35 (4), 731-740, 2009
Inhibition of mTOR activates the MAPK pathway in glioblastoma multiforme
L Albert, M Karsy, RAJ Murali, M Jhanwar-Uniyal
Cancer Genomics-Proteomics 6 (5), 255-261, 2009
Neuroprotective strategies and the underlying molecular basis of cerebrovascular stroke
M Karsy, A Brock, J Guan, P Taussky, MYS Kalani, MS Park
Neurosurgical focus 42 (4), E3, 2017
Managing overlapping surgery: an analysis of 1018 neurosurgical and spine cases
J Guan, AA Brock, M Karsy, WT Couldwell, MH Schmidt, JRW Kestle, ...
Journal of neurosurgery 127 (5), 1096-1104, 2016
Impact of removed tumor volume and location on patient outcome in glioblastoma
AW Awad, M Karsy, N Sanai, R Spetzler, Y Zhang, Y Xu, MA Mahan
Journal of neuro-oncology 135 (1), 161-171, 2017
The genetic basis of intradural spinal tumors and its impact on clinical treatment
M Karsy, J Guan, W Sivakumar, JA Neil, MH Schmidt, MA Mahan
Neurosurgical focus 39 (2), E3, 2015
Deciphering the signaling pathways of cancer stem cells of glioblastoma multiforme: role of Akt/mTOR and MAPK pathways.
M Jhanwar-Uniyal, L Albert, E McKenna, M Karsy, P Rajdev, A Braun, ...
Advances in enzyme regulation 51 (1), 164-170, 2010
Medical management of meningiomas: current status, failed treatments, and promising horizons
M Karsy, J Guan, A Cohen, H Colman, RL Jensen
Neurosurgery Clinics 27 (2), 249-260, 2016
Pharmacologic management of acute spinal cord injury
M Karsy, G Hawryluk
Neurosurgery Clinics 28 (1), 49-62, 2017
Anterior two-thirds corpus callosotomy via stereotactic laser ablation
M Karsy, DM Patel, K Halvorson, V Mortimer, RJ Bollo
Neurosurgical focus 44 (videosuppl2), V2, 2018
Surgical treatment of glioblastoma in the elderly: the impact of complications
M Karsy, N Yoon, L Boettcher, R Jensen, L Shah, J MacDonald, ...
Journal of neuro-oncology 138 (1), 123-132, 2018
Molecular, histopathological, and genomic variants of glioblastoma
M Karsy, T Huang, G Kleinman, G Karpel-Massler
Front Biosci (Landmark Ed) 19, 1065-1087, 2014
The system can't perform the operation now. Try again later.
Articles 1–20